Oakleaf Care (Hartwell) Limited has been acquired by CareTech Holdings Plc
The private shareholders of Oakleaf Care (Hartwell) Limited (Oakleaf) have sold the company to CareTech Holdings Plc (CareTech) for an undisclosed consideration.
Oakleaf Care provides brain injury rehabilitation to adult males requiring specialist care and long-term support. Based in Northamptonshire, UK, the group operates over 80 beds across a number of sites, with highly trained staff providing a seamless rehabilitation pathway of care for men with acquired brain injury (ABI). The business continues to expand, with a new 22-bed care home opening this quarter bringing the total to over 100 beds.
CareTech is a provider of specialist social care services in the UK, supporting adults and children with a wide range of complex needs across more than 250 specialist services. This acquisition gives CareTech a presence in ABI rehabilitation, enabling it to offer additional pathways to its client care group.
Oaklins Smith & Williamson, based in the UK, advised the seller in this transaction.


Talk to the deal team
Brian Livingston
Oaklins Evelyn Partners
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more